Nihon Kohden Corporation (NHNKY) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Devices Branche. Der Hauptsitz des Unternehmens ist in Tokyo, Japan. Der aktuelle CEO ist Hirokazu Ogino.
NHNKY hat IPO-Datum 2013-09-27, 5,891 Vollzeitbeschäftigte, gelistet an der Other OTC, eine Marktkapitalisierung von $3.33B.
Nihon Kohden Corporation is a leading medical device manufacturer headquartered in Tokyo, Japan, with operations across Japan, the Americas, Europe, and Asia. The company designs, produces, and maintains a comprehensive portfolio of medical electronic equipment, including physiological monitoring systems, patient monitors, diagnostic equipment, treatment devices such as defibrillators and ventilators, and clinical analyzers. Its product range encompasses electrocardiographs, pacemakers, anesthesia machines, cochlear implants, and related consumables and services. In addition to its core medical device business, Nihon Kohden operates insurance brokerage and technology licensing divisions. Since its incorporation in 1951, the company has established itself as a global provider of critical care and diagnostic solutions for hospitals and healthcare facilities worldwide.
